Researcher

Dr Sophy Shih

Keywords

Biography

Dr Sophy Shih is a health economist with demonstrated expertise in economic evaluation and health service research. She has extensive knowledge of designing and implementing trial-based economic assessments, performing economic evaluations, and building economic models. Dr Shih was trained in health economics, public health and biomedical science. She has worked on a broad range of topics including viral infection, rare genetic disease,...view more

Dr Sophy Shih is a health economist with demonstrated expertise in economic evaluation and health service research. She has extensive knowledge of designing and implementing trial-based economic assessments, performing economic evaluations, and building economic models. Dr Shih was trained in health economics, public health and biomedical science. She has worked on a broad range of topics including viral infection, rare genetic disease, cancer, diabetes, psycho-oncology, and disability with a focus on intervention research of prevention and screening. 

Dr Shih joined the SERP Program at the Kirby Institute and the NPESU at the Centre for Big Data Research in Health as a Senior Research Fellow/Health Economist in 2019. Her current working program includes the TEMPO study, an RCT investigating HCV point of care testing to improve treatment uptake, cost-effectiveness analyses of HCV testing and treatment in NSW prisons, and the economic assessment of accelerating the uptake of initiatives to address HIV drug resistance surveillance in Papua New Guinea (ACTUP-PNG study).

Dr Shih was a subcommittee member of the Clinical Guidelines Network at Cancer Council Australia and co-authored the “Economics of Keratinocyte Cancer” chapter of the NHMRC endorsed clinical guidelines “Clinical Practice Guidelines for Keratinocyte Cancer”.


My Grants

  1. Grebely J, Shih S TF, Wiseman V. Health Economic Evaluation for the NSW dried blood spot (DBS) HIV and HCV Testing Pilot Program. New South Wales Health, 2021.

 


My Qualifications

BS, MPH, DrPHGradDipEco


My Research Activities

 Dr Shih has collaborated with infectious disease colleagues since she joined the Kirby Institute in 2019. Her current work on developing the health economics framework for point-of-care testing of infectious diseases will inform testing scale-up. Dr Shih is a CI on an NHMRC partnership grant (ETHOS III study) to examine scale-up of point-of-care hepatitis C RNA testing in drug treatment clinics and a CI on the NSW Health funded study evaluating the dried blood spot (DBS) testing for HIV/HCV. Additionally, Dr Shih is the project economist for two clinical trials assessing HCV testing/treatment among people in prisons (SToP-C study) and point-of-care HCV RNA testing in people who inject drugs (TEMPO study).


My Research Supervision


Supervision keywords


Areas of supervision

Health Economics, Economic Evaluation


Currently supervising

Huei Jiuan Wu (PhD candidate, Kirby Institute) - Effect of point-of-care HCV testing with rapid initiation of direct-acting antiviral therapy for elimination of hepatitis C among gay and bisexual men by 2030 in Taiwan: a modeling study and cost-effectiveness analysis


Quang Nguyen (PhD candidate, Kirby Institute) - Modelling the cost-effectiveness of point-of-care HIV viral load testing and HIV drug resistance monitoring when provided as part of routine HIV treatment and care services in PNG
View less